HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders
Breast Cancer Update
00:00
Patient preferences for early intervention
They discuss counseling informed patients about tradeoffs of early switch for PFS gain versus testing burden.
Play episode from 51:51
Transcript
